257 related articles for article (PubMed ID: 26860335)
1. In situ vaccination for the treatment of cancer.
Hammerich L; Bhardwaj N; Kohrt HE; Brody JD
Immunotherapy; 2016; 8(3):315-30. PubMed ID: 26860335
[TBL] [Abstract][Full Text] [Related]
2. Harnessing dendritic cells in cancer.
Apetoh L; Locher C; Ghiringhelli F; Kroemer G; Zitvogel L
Semin Immunol; 2011 Feb; 23(1):42-9. PubMed ID: 21295491
[TBL] [Abstract][Full Text] [Related]
3. In situ antitumor vaccination: Targeting the tumor microenvironment.
Li H; Yu J; Wu Y; Shao B; Wei X
J Cell Physiol; 2020 Jul; 235(7-8):5490-5500. PubMed ID: 32030759
[TBL] [Abstract][Full Text] [Related]
4. Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future.
Fournier P; Schirrmacher V
BioDrugs; 2013 Feb; 27(1):35-53. PubMed ID: 23329400
[TBL] [Abstract][Full Text] [Related]
5. Next generation approaches for tumor vaccination.
Patel A; Kaufman HL; Disis ML
Chin Clin Oncol; 2017 Apr; 6(2):19. PubMed ID: 28482672
[TBL] [Abstract][Full Text] [Related]
6. Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application.
Trevor KT; Cover C; Ruiz YW; Akporiaye ET; Hersh EM; Landais D; Taylor RR; King AD; Walters RE
Cancer Immunol Immunother; 2004 Aug; 53(8):705-14. PubMed ID: 15048588
[TBL] [Abstract][Full Text] [Related]
7. Cancer vaccines. Any future?
Myc LA; Gamian A; Myc A
Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):249-59. PubMed ID: 21644030
[TBL] [Abstract][Full Text] [Related]
8. Cancer immunotherapy: moving forward with peptide T cell vaccines.
Kumai T; Fan A; Harabuchi Y; Celis E
Curr Opin Immunol; 2017 Aug; 47():57-63. PubMed ID: 28734176
[TBL] [Abstract][Full Text] [Related]
9. Expansion of HER2/neu-specific T cells ex vivo following immunization with a HER2/neu peptide-based vaccine.
Knutson KL; Disis ML
Clin Breast Cancer; 2001 Apr; 2(1):73-9. PubMed ID: 11899386
[TBL] [Abstract][Full Text] [Related]
10. Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy.
Rolinski J; Hus I
J Immunotoxicol; 2014 Oct; 11(4):311-8. PubMed ID: 24495309
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells for specific cancer immunotherapy.
Meidenbauer N; Andreesen R; Mackensen A
Biol Chem; 2001 Apr; 382(4):507-20. PubMed ID: 11405216
[TBL] [Abstract][Full Text] [Related]
12. Tumor vaccine: current trends in antigen specific immunotherapy.
Baral R
Indian J Exp Biol; 2005 May; 43(5):389-406. PubMed ID: 15900903
[TBL] [Abstract][Full Text] [Related]
13. Editorial: Approaches to Advance Cancer Vaccines to Clinical Utility.
Van Nuffel AMT; Boudousquié C; Tuyaerts S
Front Immunol; 2019; 10():2032. PubMed ID: 31507617
[No Abstract] [Full Text] [Related]
14. Failure of cancer vaccines: the significant limitations of this approach to immunotherapy.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 2000; 20(4):2665-76. PubMed ID: 10953341
[TBL] [Abstract][Full Text] [Related]
15. Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccines.
Schijns V; Tartour E; Michalek J; Stathopoulos A; Dobrovolskienė NT; Strioga MM
Cytotherapy; 2014 Apr; 16(4):427-39. PubMed ID: 24280238
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapeutic potential of whole tumour cells.
Ward S; Casey D; Labarthe MC; Whelan M; Dalgleish A; Pandha H; Todryk S
Cancer Immunol Immunother; 2002 Sep; 51(7):351-7. PubMed ID: 12192534
[TBL] [Abstract][Full Text] [Related]
17. At the bench: Engineering the next generation of cancer vaccines.
Shae D; Baljon JJ; Wehbe M; Becker KW; Sheehy TL; Wilson JT
J Leukoc Biol; 2020 Oct; 108(4):1435-1453. PubMed ID: 31430398
[TBL] [Abstract][Full Text] [Related]
18. Vaccination for leukemia.
Molldrem JJ
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):13-8. PubMed ID: 16399579
[TBL] [Abstract][Full Text] [Related]
19. In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf.
Hammerich L; Binder A; Brody JD
Mol Oncol; 2015 Dec; 9(10):1966-81. PubMed ID: 26632446
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic cancer vaccines.
Acres B; Paul S; Haegel-Kronenberger H; Calmels B; Squiban P
Curr Opin Mol Ther; 2004 Feb; 6(1):40-7. PubMed ID: 15011780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
